地塞米松植入剂用于治疗与特发性黄斑毛细血管扩张相关的水肿。 - Suppr

Suppr

超能文献

Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.

作者信息

Sandali Otman, Akesbi Jad, Rodallec Thibaut, Laroche Laurent, Nordmann Jean-Philippe

出版信息

Can J Ophthalmol. 2013 Aug;48(4):e78-80. doi: 10.1016/j.jcjo.2013.01.022.

DOI:10.1016/j.jcjo.2013.01.022

PMID:23931489

Abstract

摘要

相似文献

Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.

Can J Ophthalmol. 2013 Aug;48(4):e78-80. doi: 10.1016/j.jcjo.2013.01.022.

Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.

Retina. 2012 Jul;32(7):1289-94. doi: 10.1097/IAE.0b013e318242b838.

A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.

Retina. 2015 Aug;35(8):1604-14. doi: 10.1097/IAE.0000000000000533.

Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant.

Retina. 2014 Apr;34(4):719-24. doi: 10.1097/IAE.0b013e3182a48958.

Bevacizumab and macular edema.

Ophthalmology. 2008 Mar;115(3):585. doi: 10.1016/j.ophtha.2007.10.017.

Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab.

Middle East Afr J Ophthalmol. 2015 Jul-Sep;22(3):396-8. doi: 10.4103/0974-9233.159779.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.

Acta Ophthalmol. 2014 Dec;92(8):e694-6. doi: 10.1111/aos.12424. Epub 2014 Apr 16.

Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.

Ophthalmic Res. 2013;49(4):205-8. doi: 10.1159/000346130. Epub 2013 Jan 29.

Differential effects of triamcinolone and bevacizumab in central retinal vein occlusion.

Can J Ophthalmol. 2011 Feb;46(1):88-9. doi: 10.3129/i10-080.

引用本文的文献

Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1.

Case Rep Ophthalmol. 2021 Apr 6;12(1):92-97. doi: 10.1159/000509850. eCollection 2021 Jan-Apr.

Local delivery of corticosteroids in clinical ophthalmology: A review.

Clin Exp Ophthalmol. 2020 Apr;48(3):366-401. doi: 10.1111/ceo.13702. Epub 2020 Jan 22.

Widening use of dexamethasone implant for the treatment of macular edema.

Drug Des Devel Ther. 2017 Aug 16;11:2359-2372. doi: 10.2147/DDDT.S138922. eCollection 2017.

CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS.

Retina. 2018 Jan;38 Suppl 1(Suppl 1):S114-S122. doi: 10.1097/IAE.0000000000001724.

Macular oedema related to idiopathic macular telangiectasia type 1 treated with dexamethasone intravitreal implant (ozurdex).

Case Rep Ophthalmol Med. 2014;2014:231913. doi: 10.1155/2014/231913. Epub 2014 Jun 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验